John Walton Muscular Dystrophy Research Centre
Newcastle upon Tyne, NE1 3BZ, United Kingdom
Location status: Recruiting
Location contact
Chiara Marini-Bettolo, MD, PhD
PRINCIPAL_INVESTIGATOR
Registry Project Manager and Curator
CONTACT
NCT Number: NCT04003363
Myotonic dystrophy (dystrophia myotonica - DM) exists in two forms, usually referred to as DM1 (type 1) and DM2 (type 2). Both conditions are genetic disorders but each affects a different gene. DM1 is the most common adult-onset muscular dystrophy, and is thought to affect at least 1 in 8,000 people worldwide.
The aim is to facilitate a questionnaire based research study in order to better characterise and understand the disease in the UK. By maintaining a national registry this will help identify potential participants eligible for clinical trials in the future.
Interested in participating?
Request InfoAll sexes
Observational
Newcastle upon Tyne, NE1 3BZ, United Kingdom
Location status: Recruiting
Chiara Marini-Bettolo, MD, PhD
PRINCIPAL_INVESTIGATOR
Registry Project Manager and Curator
CONTACT
The UK DM Patient Registry (https://www.dm-registry.org/uk/) aims to recruit any individual, from anywhere within the United Kingdom, with a diagnosis of myotonic dystrophy. Participants may be referred to the registry by health care professionals, or genetic testing/laboratory centres who are aware of the registry. Alternatively, a participant may have discovered the registry via promotional activities or by their own online searches. After completing the consent process, participants are able to enter information on to the registry platform (note all forms are also available offline as well). This is an ongoing database and all participants will invited to update their information on an annual basis.
The registry is sponsored by Muscular Dystrophy UK, Cure-DM and the Myotonic Dystrophy Support Group.
The database is divided into two main sections:
The database is designed to be self reporting, however where specialised clinical or genetic information is required, the neuromuscular specialist in charge of the participants care can be invited to provide some additional information. The participant is able to select a health care provider from a pre-populated list at registration stage, if they wish to (optional feature). This information is included in the patient information and consent.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants who have volunteered to participate will complete various questionnaires relating to their condition.
Time frame: 12 months
Patient reported myotonic dystrophy clinical diagnosis, symptoms relating to muscle weakness, motor function, medication use, family history and ethnicity.
Time frame: 12 months
Clinician reported patient cardiac measures, medication use, respiratory measures and genetic confirmation of myotonic dystrophy.
Contact information is provided by the study sponsor or research team.
Registries Team
CONTACT
Registry Project Manager and Curator
CONTACT
Newcastle University
Other
The UK National Registry for Myotonic Dystrophy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07486934
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
La Jolla, California, United States
View Trial DetailsNCT07700225
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
Richmond, Virginia, United States
View Trial DetailsNCT06844214
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Gainesville, Florida, United States
View Trial DetailsNCT07321977
Central Nervous System Diseases, Charcot-Marie-Tooth
Paris, France
View Trial Details